Page 2 - Biotechnology

Biotech firm Bharat Serums & Vaccines working to reduce import dependence

Firm is develop recombinant products in hormones, eyes acquisitions in South East Asia

Years after Bt cotton, GEAC clears environmental release of GM mustard

First crop to get such recommendation since Bt cotton in years, say experts

New Covid variants spreading across the globe: what are the risk?

Amid the surge in the new and recombinant variants, scientists across the world are now watching out for variants which could turn into variants of concern soon

And now, a seaweed-based nutraceutical cure for fatty liver disease

Pre-clinical trials show no evidence of side effects in the product, which is the ninth such to be developed from marine organisms by Kochi-based CMFRI

Jamia Millia to release first merit list for UG admission on Sept 26

JMI UG admission 2022 to begin from September 26. Candidates can visit the official website for further updates

Planet Scuba India ropes in CREST to manufacture dive equipment in India

The company will introduce CREST Diving to DRDO's DEBEL and will aim to make India an alternative to China as a manufacturer of dive equipment

Mylab, firm that makes kits to detect Covid, starts pathology test facility

"We are now getting to 'wet' pathology tests like blood tests etc and we have set up a centre which will have minimal human intervention and maximum automation

Biocon net profit rises 71% to Rs 144 cr in June quarter; revenue rises 23%

Biotechnology major Biocon on Wednesday reported a 71 per cent increase in consolidated net profit at Rs 144 crore for the June quarter on the back of robust growth across business verticals. The company had posted a net profit of Rs 84 crore in the April-June quarter of the previous fiscal. Total revenue rose to Rs 2,217 crore in the first quarter as compared with Rs 1,808 crore in the year-ago period, Biocon said in a regulatory filing. Biocon Executive Chairperson Kiran Mazumdar-Shaw said revenues grew as a result of robust growth in both biosimilar and generics verticals. "Our financial performance this quarter includes the impact of annual increments in personnel costs as well as increased input and freight costs, pursuant to pandemic and geopolitical disruptions of global supply chains," she added. All the company businesses are poised for the next phase of sustainable growth which has been challenged during the two years of the Covid pandemic, Mazumdar-Shaw said.

Procedural issues continue to hinder commercialisation of GM crops in India

Two decades after Bt cotton made its debut in India, commercialisation of genetically modified crops remains mired in complex procedural rules

Diverse population, climatic zones behind rise in biotech sector: PM Modi

Highlighting the potential of bio start-ups in India, Narendra Modi on Thursday said India's diverse population and climatic zones are among the top factors behind the growth of the biotech industry.

North India's first Industrial Biotech Park inaugurated at Kathua in J&K

Jammu and Kashmir (J&K) Lieutenant Governor, Manoj Sinha and Union minister Jitendra Singh on Saturday inaugurated the north India's first Industrial Biotech Park constructed at Ghatti near Kathua.

Samsung to spend $360 billion on microchips, biotech over five years

Samsung promised in a statement to create 80,000 jobs through 2026, mostly in semiconductors and biopharmaceuticals.

Ireland regulator reports manufacturing deficiency at Biocon's plant

Biocon Biologics is a subsidiary of Biocon Ltd

Indian-American Congressman Ro Khanna named to National Security Commission

Indian-American Congressman Ro Khanna was on Thursday named to the National Security Commission on Emerging Biotechnology

Biocon beefs up biosimilar portfolio with $3.3-bn Viatris deal, shares fall

The company in a statement said that its subsidiary Biocon Biologics has inked a pact to acquire Viatris Inc's biosimilars business for consideration of up to USD 3.335 billion

Covid vaccine sales push Moderna to $12-bn profit in 2021

The vaccine maker's COVID-19 shots, which are now available in more than 70 countries, totalled USD 17.7 billion in sales last year, their first full year on the market

Gujarat chief minister Bhupendra Patel unveils new biotechnology policy

CM Bhupendra Patel unveiled a new biotechnology policy for the next five years that seeks to make Gujarat one of the leading states in the country in the key sector

Biocon rises over 3% as biotech major sees strong Dec qtr numbers

Notwithstanding the muted broader market trend, shares of Biocon Ltd surged over 3 per cent on Friday after the biotechnology major reported strong December quarter earnings. On BSE, the stock opened at Rs 363, then touched a high of Rs 382.45, registering a gain of 5.09 per cent over its last close. The stock finally ended at Rs 376.60, up 3.49 per cent. In a similar trend on NSE, the stock opened at Rs 364.00, then jumped 5.02 per cent and touched an early high of Rs 382.50 in initial deals. It finally settled at Rs 376.45, up 3.36 per cent. On Thursday, biotechnology major Biocon Ltd reported a 17.68 per cent rise in consolidated net profit at Rs 219.6 crore for the third quarter ended December 31, 2021. The company had posted a consolidated net profit of Rs 186.6 crore in the same quarter of the previous fiscal. Consolidated total income in the third quarter this fiscal stood at Rs 2,222.5 crore, compared to Rs 1,885.3 crore a year ago. The biosimilars vertical clocked revenue

Biotech firm Mylab developing test to screen multiple Covid variants

Mylab MD Rawal said the firm is making both hardware and software for the test, and it will be ready in the next two months or so

Rajasthan becomes 1st state to develop facility for Genome Sequencing

The facility for genome Sequencing has been started in the SMS Medical College